270 related articles for article (PubMed ID: 21769918)
41. Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion.
Ding Y; Milosavljevic T; Alahari SK
Mol Cell Biol; 2008 Jun; 28(11):3742-56. PubMed ID: 18332102
[TBL] [Abstract][Full Text] [Related]
42. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
[TBL] [Abstract][Full Text] [Related]
43. Identification of DAPK as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis.
Ivanovska J; Tregubova A; Mahadevan V; Chakilam S; Gandesiri M; Benderska N; Ettle B; Hartmann A; Söder S; Ziesché E; Fischer T; Lautscham L; Fabry B; Segerer G; Gohla A; Schneider-Stock R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1720-9. PubMed ID: 23702034
[TBL] [Abstract][Full Text] [Related]
44. The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor.
Peng S; Fan S; Li X; Wang L; Liu H; Zhou M; Wang L; Shen S; Li G
Cancer Sci; 2007 Mar; 98(3):341-9. PubMed ID: 17270023
[TBL] [Abstract][Full Text] [Related]
45. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus.
Yokoo T; Toyoshima H; Miura M; Wang Y; Iida KT; Suzuki H; Sone H; Shimano H; Gotoda T; Nishimori S; Tanaka K; Yamada N
J Biol Chem; 2003 Dec; 278(52):52919-23. PubMed ID: 14530263
[TBL] [Abstract][Full Text] [Related]
46. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.
Zhao R; Yang HY; Shin J; Phan L; Fang L; Che TF; Su CH; Yeung SC; Lee MH
Cell Cycle; 2013 Mar; 12(6):935-43. PubMed ID: 23421998
[TBL] [Abstract][Full Text] [Related]
47. Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration.
Nishita M; Tomizawa C; Yamamoto M; Horita Y; Ohashi K; Mizuno K
J Cell Biol; 2005 Oct; 171(2):349-59. PubMed ID: 16230460
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
49. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
50. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14.
Hsu S; Yamamoto T; Borke J; Walsh DS; Singh B; Rao S; Takaaki K; Nah-Do N; Lapp C; Lapp D; Foster E; Bollag WB; Lewis J; Wataha J; Osaki T; Schuster G
J Pharmacol Exp Ther; 2005 Mar; 312(3):884-90. PubMed ID: 15537824
[TBL] [Abstract][Full Text] [Related]
51. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
Li G; Domenico J; Lucas JJ; Gelfand EW
J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
[TBL] [Abstract][Full Text] [Related]
52. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
53. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
54. A Beckwith-Wiedemann-Associated
Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
[TBL] [Abstract][Full Text] [Related]
55. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
[TBL] [Abstract][Full Text] [Related]
56. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
Mishra S; Lin CL; Huang TH; Bouamar H; Sun LZ
Mol Cancer; 2014 Sep; 13():212. PubMed ID: 25216674
[TBL] [Abstract][Full Text] [Related]
58. Functional Versatility of the CDK Inhibitor p57
Creff J; Besson A
Front Cell Dev Biol; 2020; 8():584590. PubMed ID: 33117811
[TBL] [Abstract][Full Text] [Related]
59. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells.
Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500
[TBL] [Abstract][Full Text] [Related]
60. Simvastatin Attenuates Neuropathic Pain by Inhibiting the RhoA/LIMK/Cofilin Pathway.
Qiu Y; Chen WY; Wang ZY; Liu F; Wei M; Ma C; Huang YG
Neurochem Res; 2016 Sep; 41(9):2457-69. PubMed ID: 27216618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
